www.public4you.fora.pl

colp1ate1xd

lectis S.A. (ALCLS) - Financial and Strategic Analysis Review
Cellectis S.A. (Cellectis) is a biotechnology company, engaged in the development of high-precision [link widoczny dla zalogowanych], high-performance systems for DNA surgery and cell reprogramming. The company has two subsidiaries, namely, Cellectis Genome Surgery and Cellectis Bioresearch. The products of the company includes cGPS CHO-K1 Full Kit and cGPS Custom CHO-K1 Full Kit. Cellectis Genome Surgery engages in development of programs for treating formerly incurable monogenic diseases and chronic DNA-virus infections.
Cellectis S.A. Key Recent Developments
Mar 11, 2010: European Patent Office Issues Written Decision Confirming Cellectis' Loss of Patent Protection for Single-Chain Meganucleases in Europe
Mar 08 [link widoczny dla zalogowanych], 2010: Precision BioSciences Gets Second ACP For Cellectis Core Technology
Sep 29, 2009: US Patent Office To Reexamine Cellectis Patents Involved In Litigation
This comprehensive SWOT profile of Cellectis S.A. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cellectis including a detailed SWOT analysis [link widoczny dla zalogowanych], and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
For more information please visit :
/reports/Cellectis-S-A-ALCLS-Financial-and-Strategic-Analysis-Review-51564.html